Tech Company Financing Transactions

Astute Medical Funding Round

Astute Medical, operating out of San Diego, secured $40.4 million from MPM Capital, De Novo Ventures and Delphi Ventures.

Transaction Overview

Company Name
Announced On
6/7/2012
Transaction Type
Venture Equity
Amount
$40,400,000
Round
Series C
Investors

MPM Capital (Lead Investor) (James Scopa)

De Novo Ventures (Fred Dotzler)

Delphi Ventures

Domain Associates (James Blair)

Johnson & Johnson Development Corporation

Kaiser Permanente Ventures

Proceeds Purpose
The Company intends to use the proceeds to begin commercializing its first product, as well as to advance and expand its research, development and validation of biomarker-based laboratory tests.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
3550 General Atomics Ct. Building 02/620
San Diego, CA 92121
USA
Email Address
Overview
Astute Medical provides diagnosis of high-risk medical conditions through the identification and validation of protein biomarkers.
Profile
Astute Medical LinkedIn Company Profile
Social Media
Astute Medical Company Twitter Account
Company News
Astute Medical News
Facebook
Astute Medical on Facebook
YouTube
Astute Medical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Chris Hibberd
  Chris Hibberd LinkedIn Profile  Chris Hibberd Twitter Account  Chris Hibberd News  Chris Hibberd on Facebook
Chief Financial Officer
Todd Myers
  Todd Myers LinkedIn Profile  Todd Myers Twitter Account  Todd Myers News  Todd Myers on Facebook
Chief Scientific Officer
Paul McPherson
  Paul McPherson LinkedIn Profile  Paul McPherson Twitter Account  Paul McPherson News  Paul McPherson on Facebook
VP - Engineering
Joe Anderberg
  Joe Anderberg LinkedIn Profile  Joe Anderberg Twitter Account  Joe Anderberg News  Joe Anderberg on Facebook
VP - Product Management
Ravi Vijayendran
  Ravi Vijayendran LinkedIn Profile  Ravi Vijayendran Twitter Account  Ravi Vijayendran News  Ravi Vijayendran on Facebook
VP - Regulatory Affairs
Karin Hughes
  Karin Hughes LinkedIn Profile  Karin Hughes Twitter Account  Karin Hughes News  Karin Hughes on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/7/2012: Vets First Choice venture capital transaction
Next: 6/7/2012: Fanatics.com venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary